Get the Stockscreener App
1.8168
3.87%
-0.0732
After Hours:
1.88
0.0632
+3.48%
China Pharma Holdings Inc. stock is traded at $1.8168, with a volume of 40,418.
It is down -3.87% in the last 24 hours and up +28.40% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.89
Open:
$1.85
24h Volume:
40,418
Relative Volume:
0.38
Market Cap:
$5.93M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-5.4071
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
+8.47%
1M Performance:
+28.40%
6M Performance:
-32.46%
1Y Performance:
-22.03%
1-Day Range:
$1.7601
$1.875
1-Week Range:
$1.59
$2.0299
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.8168 | 5.97M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Combining machine learning predictions for China Pharma Holdings Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
China Pharma Holdings Inc. stock prediction for this weekTreasury Yields & Fast Moving Stock Trade Plans - Newser
Is it time to cut losses on China Pharma Holdings Inc.Portfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Is China Pharma Holdings Inc. stock ready for a breakout2025 Price Action Summary & Safe Entry Trade Reports - Newser
Reversal indicators forming on China Pharma Holdings Inc. stockJuly 2025 News Drivers & Intraday High Probability Setup Alerts - Newser
How high can China Pharma Holdings Inc. stock go2025 Price Targets & Community Consensus Picks - Newser
Can China Pharma Holdings Inc. recover in the next quarterWeekly Gains Summary & Long-Term Capital Growth Ideas - Newser
Institutional scanner results for China Pharma Holdings Inc.2025 Price Action Summary & AI Driven Price Forecasts - Newser
What MACD signals say about China Pharma Holdings Inc.2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
What MACD and RSI say about China Pharma Holdings Inc.July 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
What recovery options are there for China Pharma Holdings Inc.2025 Short Interest & High Accuracy Trade Signal Alerts - Newser
Published on: 2025-09-12 14:10:47 - Newser
Can technical indicators confirm China Pharma Holdings Inc.’s reversalMarket Activity Recap & Verified Swing Trading Watchlists - Newser
Using data tools to time your China Pharma Holdings Inc. exitJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Signal strength of China Pharma Holdings Inc. stock in tech scanners2025 Volatility Report & Weekly Consistent Profit Watchlists - Newser
Building trade automation scripts for China Pharma Holdings Inc.July 2025 Selloffs & Precise Swing Trade Alerts - Newser
Sentiment analysis tools applied to China Pharma Holdings Inc.2025 Stock Rankings & Community Consensus Stock Picks - Newser
Published on: 2025-09-12 05:31:06 - Newser
News impact scoring models applied to China Pharma Holdings Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Published on: 2025-09-12 01:31:28 - Newser
Will China Pharma Holdings Inc. bounce back from current supportPortfolio Update Summary & Entry Point Strategy Guides - Newser
Analyzing net buyer seller activity in China Pharma Holdings Inc.Forecast Cut & Daily Profit Focused Screening - Newser
China Pharma Holdings Inc. stock trendline breakdownJuly 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Regression analysis insights on China Pharma Holdings Inc. performanceTrade Ideas & Technical Pattern Based Signals - Newser
How to track smart money flows in China Pharma Holdings Inc.Inflation Watch & Target Return Focused Picks - Newser
Is a relief rally coming for China Pharma Holdings Inc. holdersShort Setup & Weekly High Conviction Trade Ideas - Newser
Using Bollinger Bands to evaluate China Pharma Holdings Inc.Market Performance Report & Weekly Hot Stock Watchlists - Newser
Long term hold vs stop loss in China Pharma Holdings Inc.2025 Market Overview & Real-Time Buy Signal Notifications - Newser
How to use a screener to detect China Pharma Holdings Inc. breakouts2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):